Traditional Chinese medicines in the treatment of hepatocellular cancers: A systematic review and meta-analysis

69Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background. Liver cancer is a common malignancy with a high mortality rate. Given the poor prognosis associated with this cancer, many patients seek additional therapies that may improve quality of life or survival. Several Traditional Chinese Medicines (TCM) have been evaluated in clinical trials, but little is known about them outside of China. Methods. We searched independently and in duplicate 8 electronic databases, including 2 Chinese language databases, until February 2009. We included any randomized clinical trials (RCT) evaluating a TCM oral preparation for the treatment of hepatocellular cancers. We abstracted data on survival, tumor response, and performance scores. We conducted a random-effects meta-analysis and applied a meta-regression analysis. Results. We included 45 RCTs (n = 3,236). All studies employed an active control group. In general, the reporting of methodological issues was poor. We analyzed data from 37 trials reporting on complete response effects score (Relative Risk [RR] of 1.26 (95 CI, 1.04-1.52, P = 0.01, I2= 0%, P = 0.99). Products containing ginseng, astragalus and mylabris had a larger treatment effect (OR 1.34, 95% CI, 1.04-1.71, P = 0.01) than the pooled broad estimate, also the case for astragalus-based treatments (OR 1.35, 95% CI, 1.001-1.80. P = 0.048). We examined survival rates and pooled 15 studies reporting on 6 month outcomes (RR 1.10, 95% CI, 1.04-1.15, P = < 0.0001, I2= 0%, P = 0.60). This effect was consistent at other prospective dates, including 12 months (22 trials, RR 1.26, 95% CI, 1.17-1.36, P = < 0.0001, I2= 7%, P = 0.36), 24 months (15 trials, 1.72, 95% CI, 1.40-2.03, P = < 0.0001, I2= 0%, P = 0.75); and, at 36 months (8 trials, RR 2.40, 95% CI, 1.65-3.49, P = < 0.0001, I2= 0%, P = 0.62). Limitations. All included trials were conducted in China where emerging evidence suggests many RCTs are not, in fact, randomized. Publication bias may exist, favouring positive reports. Conclusion. Our meta-analysis displays compelling evidence of effectiveness for hepatocellular cancers that should be evaluated in high-quality and transparent clinical trials. © 2009 Wu et al; licensee BioMed Central Ltd.

References Powered by Scopus

Quantifying heterogeneity in a meta-analysis

27238Citations
N/AReaders
Get full text

Primary liver cancer: Worldwide incidence and trends

2273Citations
N/AReaders
Get full text

The statistical basis of meta-analysis.

1037Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Designing a broad-spectrum integrative approach for cancer prevention and treatment

274Citations
N/AReaders
Get full text

The role of traditional Chinese herbal medicines in cancer therapy from TCM theory to mechanistic insights

257Citations
N/AReaders
Get full text

Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: Effects on quality of life and survival

136Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Wu, P., Dugoua, J. J., Eyawo, O., & Mills, E. J. (2009). Traditional Chinese medicines in the treatment of hepatocellular cancers: A systematic review and meta-analysis. Journal of Experimental and Clinical Cancer Research, 28(1). https://doi.org/10.1186/1756-9966-28-112

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 16

52%

Researcher 7

23%

Lecturer / Post doc 5

16%

Professor / Associate Prof. 3

10%

Readers' Discipline

Tooltip

Medicine and Dentistry 25

66%

Agricultural and Biological Sciences 8

21%

Biochemistry, Genetics and Molecular Bi... 3

8%

Pharmacology, Toxicology and Pharmaceut... 2

5%

Save time finding and organizing research with Mendeley

Sign up for free